Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine

Go back to Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine
Pfizer Inc. (NYSE: PFE) Delayed: 29.77 -0.34 (1.13%)
Previous Close $30.11    52 Week High $37.39 
Open $30.00    52 Week Low $28.25 
Day High $30.09    P/E 18.04 
Day Low $29.72    EPS $1.65 
Volume 6,844,643       

Pfizer Inc. (NYSE: PFE) Delayed: 29.77 -0.34 (1.13%)
Previous Close $30.11    52 Week High $37.39 
Open $30.00    52 Week Low $28.25 
Day High $30.09    P/E 18.04 
Day Low $29.72    EPS $1.65 
Volume 6,844,643